Insider Transactions in Q1 2025 at Harmony Biosciences Holdings, Inc. (HRMY)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 21
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
1,123
-100.0%
|
$44,920
$40.0 P/Share
|
|
Jan 21
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
1,123
+50.0%
|
$37,059
$33.44 P/Share
|
|
Jan 16
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
29,475
-100.0%
|
$1,090,575
$37.41 P/Share
|
|
Jan 16
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
29,475
+50.0%
|
$972,675
$33.44 P/Share
|
|
Jan 15
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
10,507
-100.0%
|
$388,759
$37.01 P/Share
|
|
Jan 15
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
10,507
+50.0%
|
$346,731
$33.44 P/Share
|
|
Jan 13
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
SELL
Open market or private sale
|
Direct |
7,180
-100.0%
|
$265,660
$37.04 P/Share
|
|
Jan 13
2025
|
Jeffrey Dierks CHIEF COMMERCIAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
7,180
+50.0%
|
$236,940
$33.44 P/Share
|